CHADWIN SCHROEDER: Open Payments
NPI 1851356026 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 85 payments from 17 companies in 2025. Trend: 2023 $951 · 2024 $1,125 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $333 |
| Lilly USA, LLC | 15 | $271 |
| ABBVIE INC. | 17 | $225 |
| Phathom Pharmaceuticals, Inc. | 8 | $78 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Radius Health, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: MOUNJARO, VRAYLAR, Wegovy, Ozempic, UBRELVY, Rybelsus, VOQUEZNA, CAPLYTA.
Industry payments across KS — which companies pay providers there.
